Navigation Links
China Kangtai Cactus Biotech Announces Improved Milk Production in Cows From Company's Cactus Cattle Feed
Date:6/4/2008

Results Expected to Allow Company to Make Key Marketing Claims

HARBIN, China, June 4 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, announced today test results from studies conducted of cows that received the Company's Cactus Cattle Feed. The studies, which included 30 cows, were conducted in conjunction with the Company's application for a Certificate of National Invention Patent and showed cows that received the Company's Cactus Cattle Feed increased milk production by approximately 15.2% during the twenty-day trial period. In order to be granted the Certificate of National Invention Patent, the applicant is required to demonstrate that its product or invention creates significant value.

The Company also conducted a second test, evaluating the ability of cattle to produce milk under adverse environmental conditions, including cold temperatures and strong wind conditions. The study selected 100 milk cows between the age of 2.5 to 3 years, and divided them into two groups. The cows in the control group were fed with the normal feed which was made by the ranch. The cows in the experimental group received the same feed, but also added 1kg cactus cattle feed to each ton of the normal feed. The milk production of the experimental group increased to 1,372kg from 1,350kg despite the adverse conditions. The milk production of the control group decreased to 1,286kg from 1,380kg. The results suggest that the use of cactus cattle feed additives could increase milk production by 8.44%.

"We are excited by the results of these studies, as it will enhance our ability to market our cactus products, as well as increase the probability that we will be granted important patent protection," said Jinjiang Wang, President of China Kangtai Cactus. "These results further support the key role that our cactus products can play in improving the production of cattle."

The Company previously announces that its wholly-owned subsidiary Harbin Hainan Kangda Cactus Hygienical Foods Co., Ltd. had been granted The National Invention Patent of China, a key patent for the nutritional use of cactus to enhance the immune system through its ability to prevent infection and anti- inflammatory diseases. The Company was previously awarded two patents for Cactus Cattle Feed and Cactus Fish Feed by the State Intellectual Property Office and has five patents pending. These include Cactus Poultry Feed, Cactus Pig Feed, Cactus Cattle Feed Additives, Cactus Poultry Feed Additives and Cactus Pig Feed Additives.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 15 product patents and is seeking another 15 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 14 provinces and 4 municipalities.

Cautionary Statement Regarding Forward-looking Information

This press release contains forward-looking information about China Kangtai Cactus Biotech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Biotech future performance, operations and products.

For more information, please contact:

Chengzhi Wang

General Manager

China Kangtai Cactus Biotech, Inc.

Tel: +86-158-0451-2893

Email: chinakangtai@gmail.com

Web: http://www.biocactus.com

Investor Relations:

Dan Schustack

CEOcast, Inc.

China Kangtai Cactus

Tel: +1-212-732-4300

Email: dschustack@ceocast.com


'/>"/>
SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Pharma Holdings, Inc. Closes $10 Million Financing
2. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
3. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
4. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
5. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
6. China Pharma Holdings, Inc. Donates Medicine for Sichuan Earthquake Relief
7. China Biologic Products Reports First Quarter 2008 Results
8. China Biologic Products Announces First Quarter 2008 Results Conference Call
9. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
10. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
11. China Sky One Medical, Inc. Changes Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):